Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer

Precision oncology has fundamentally changed how we diagnose and treat cancer. In recent years, there has been a significant change in the management of patients with oncogene-addicted advanced-stage non–small cell lung cancer (NSCLC). Increasing amounts of identifiable oncogene drivers have led to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Concepcion, Joel, Uprety, Dipesh, Adjei, Alex A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016301/
https://www.ncbi.nlm.nih.gov/pubmed/35209703
http://dx.doi.org/10.4143/crt.2022.078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016301/
https://www.ncbi.nlm.nih.gov/pubmed/35209703
http://dx.doi.org/10.4143/crt.2022.078

Ejemplares similares